Form 4 Tracker
Jazz Pharmaceuticals plc
JAZZ

72 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 3, 2025Feb 3 10:04 PMCOZADD BRUCE C
Proposed Sale
1,500$122.31$183.5K—

View →

Jan 2, 2025Jan 2 10:00 PMCOZADD BRUCE C
Proposed Sale
1,500$123.43$185.1K—

View →

Dec 2, 2024Dec 2 11:05 PMCOZADD BRUCE C
Proposed Sale
2,000$121.17$242.3K—

View →

Dec 2, 2024Dec 2 9:20 PMCarr Patricia
Proposed Sale
53$122.49$6.5K—

View →

Nov 8, 2024Nov 8 10:55 PMPatil Neena M
Proposed Sale
3,700$123.41$456.6K—

View →

Nov 1, 2024Nov 1 7:19 PMCOZADD BRUCE C
Proposed Sale
1,000$110.84$110.8K—

View →

Sep 6, 2024Sep 5 11:50 PMHenderson Mary Elizabeth
Proposed Sale
2,691$110.00$296.0K—

View →

← Previous

Page 6 of 6

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 27, 2026Aug 31 10:45 PMRobert IannoneEVP, Global Head of R&D & CMO
Option Exercise
57,500$137.120(D)

View →

May 28, 2026Jun 1 8:06 PMSamantha PearceEVP, Chief Commercial Officer
Option Exercise
6,907$109.450(D)

View →

May 28, 2026Jun 1 8:01 PMSeamus MulliganDirector
Option Exercise
3,415$138.080(D)

View →

May 22, 2026May 27 10:13 PMRick E WinninghamDirector
Option Exercise
3,415$138.080(D)

View →

Feb 27, 2026Mar 2 10:36 PMNorbert G RiedelDirector
Option Exercise
3,415$138.080(D)

View →

Feb 26, 2026Mar 2 10:06 PMNeena M PatilEVP & Chief Legal Officer
Option Exercise
51,000$137.120(D)

View →